BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 26008899)

  • 1. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia.
    Boisson B; Laplantine E; Dobbs K; Cobat A; Tarantino N; Hazen M; Lidov HG; Hopkins G; Du L; Belkadi A; Chrabieh M; Itan Y; Picard C; Fournet JC; Eibel H; Tsitsikov E; Pai SY; Abel L; Al-Herz W; Casanova JL; Israel A; Notarangelo LD
    J Exp Med; 2015 Jun; 212(6):939-51. PubMed ID: 26008899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency.
    Boisson B; Laplantine E; Prando C; Giliani S; Israelsson E; Xu Z; Abhyankar A; Israël L; Trevejo-Nunez G; Bogunovic D; Cepika AM; MacDuff D; Chrabieh M; Hubeau M; Bajolle F; Debré M; Mazzolari E; Vairo D; Agou F; Virgin HW; Bossuyt X; Rambaud C; Facchetti F; Bonnet D; Quartier P; Fournet JC; Pascual V; Chaussabel D; Notarangelo LD; Puel A; Israël A; Casanova JL; Picard C
    Nat Immunol; 2012 Dec; 13(12):1178-86. PubMed ID: 23104095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC.
    Oda H; Beck DB; Kuehn HS; Sampaio Moura N; Hoffmann P; Ibarra M; Stoddard J; Tsai WL; Gutierrez-Cruz G; Gadina M; Rosenzweig SD; Kastner DL; Notarangelo LD; Aksentijevich I
    Front Immunol; 2019; 10():479. PubMed ID: 30936877
    [No Abstract]   [Full Text] [Related]  

  • 4. Posttranslational Modification of HOIP Blocks Toll-Like Receptor 4-Mediated Linear-Ubiquitin-Chain Formation.
    Bowman J; Rodgers MA; Shi M; Amatya R; Hostager B; Iwai K; Gao SJ; Jung JU
    mBio; 2015 Nov; 6(6):e01777-15. PubMed ID: 26578682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MyD88-Dependent Signaling Is Required for HOIP Deficiency-Induced Autoinflammation.
    Wu X; Tang Y; Zhang S; Zhao X; Lin X
    J Immunol; 2021 Jul; 207(2):542-554. PubMed ID: 34253576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Update on Autoinflammatory Diseases: Relopathies.
    Steiner A; Harapas CR; Masters SL; Davidson S
    Curr Rheumatol Rep; 2018 May; 20(7):39. PubMed ID: 29846841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-γ or IFN-α ameliorates chronic proliferative dermatitis by inducing expression of linear ubiquitin chain assembly complex.
    Tamiya H; Terao M; Takiuchi T; Nakahara M; Sasaki Y; Katayama I; Yoshikawa H; Iwai K
    J Immunol; 2014 Apr; 192(8):3793-804. PubMed ID: 24634492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shigella flexneri suppresses NF-κB activation by inhibiting linear ubiquitin chain ligation.
    de Jong MF; Liu Z; Chen D; Alto NM
    Nat Microbiol; 2016 May; 1(7):16084. PubMed ID: 27572974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biallelic human SHARPIN loss of function induces autoinflammation and immunodeficiency.
    Oda H; Manthiram K; Chavan PP; Rieser E; Veli Ö; Kaya Ö; Rauch C; Nakabo S; Kuehn HS; Swart M; Wang Y; Çelik NI; Molitor A; Ziaee V; Movahedi N; Shahrooei M; Parvaneh N; Alipour-Olyei N; Carapito R; Xu Q; Preite S; Beck DB; Chae JJ; Nehrebecky M; Ombrello AK; Hoffmann P; Romeo T; Deuitch NT; Matthíasardóttir B; Mullikin J; Komarow H; Stoddard J; Niemela J; Dobbs K; Sweeney CL; Anderton H; Lawlor KE; Yoshitomi H; Yang D; Boehm M; Davis J; Mudd P; Randazzo D; Tsai WL; Gadina M; Kaplan MJ; Toguchida J; Mayer CT; Rosenzweig SD; Notarangelo LD; Iwai K; Silke J; Schwartzberg PL; Boisson B; Casanova JL; Bahram S; Rao AP; Peltzer N; Walczak H; Lalaoui N; Aksentijevich I; Kastner DL
    Nat Immunol; 2024 May; 25(5):764-777. PubMed ID: 38609546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linear ubiquitination-mediated NF-κB regulation and its related disorders.
    Tokunaga F
    J Biochem; 2013 Oct; 154(4):313-23. PubMed ID: 23969028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HOIL-1L ligase modulates immune signalling and cell death via monoubiquitination of LUBAC.
    Fuseya Y; Fujita H; Kim M; Ohtake F; Nishide A; Sasaki K; Saeki Y; Tanaka K; Takahashi R; Iwai K
    Nat Cell Biol; 2020 Jun; 22(6):663-673. PubMed ID: 32393887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic insights into the subversion of the linear ubiquitin chain assembly complex by the E3 ligase IpaH1.4 of
    Liu J; Wang Y; Wang D; Wang Y; Xu X; Zhang Y; Li Y; Zhang M; Gong X; Tang Y; Shen L; Li M; Pan L
    Proc Natl Acad Sci U S A; 2022 Mar; 119(12):e2116776119. PubMed ID: 35294289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis.
    Peltzer N; Darding M; Montinaro A; Draber P; Draberova H; Kupka S; Rieser E; Fisher A; Hutchinson C; Taraborrelli L; Hartwig T; Lafont E; Haas TL; Shimizu Y; Böiers C; Sarr A; Rickard J; Alvarez-Diaz S; Ashworth MT; Beal A; Enver T; Bertin J; Kaiser W; Strasser A; Silke J; Bouillet P; Walczak H
    Nature; 2018 May; 557(7703):112-117. PubMed ID: 29695863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling.
    Elton L; Carpentier I; Staal J; Driege Y; Haegman M; Beyaert R
    FEBS J; 2016 Feb; 283(3):403-12. PubMed ID: 26573773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliotoxin suppresses NF-κB activation by selectively inhibiting linear ubiquitin chain assembly complex (LUBAC).
    Sakamoto H; Egashira S; Saito N; Kirisako T; Miller S; Sasaki Y; Matsumoto T; Shimonishi M; Komatsu T; Terai T; Ueno T; Hanaoka K; Kojima H; Okabe T; Wakatsuki S; Iwai K; Nagano T
    ACS Chem Biol; 2015 Mar; 10(3):675-81. PubMed ID: 25494483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LUBAC accelerates B-cell lymphomagenesis by conferring resistance to genotoxic stress on B cells.
    Jo T; Nishikori M; Kogure Y; Arima H; Sasaki K; Sasaki Y; Nakagawa T; Iwai F; Momose S; Shiraishi A; Kiyonari H; Kagaya N; Onuki T; Shin-Ya K; Yoshida M; Kataoka K; Ogawa S; Iwai K; Takaori-Kondo A
    Blood; 2020 Aug; 136(6):684-697. PubMed ID: 32325488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. --LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammation.
    Zinngrebe J; Rieser E; Taraborrelli L; Peltzer N; Hartwig T; Ren H; Kovács I; Endres C; Draber P; Darding M; von Karstedt S; Lemke J; Dome B; Bergmann M; Ferguson BJ; Walczak H
    J Exp Med; 2016 Nov; 213(12):2671-2689. PubMed ID: 27810922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical and biological evaluation of optimized stapled peptide inhibitors of the linear ubiquitin chain assembly complex (LUBAC).
    Aguilar-Alonso F; Whiting AL; Kim YJ; Bernal F
    Bioorg Med Chem; 2018 Mar; 26(6):1179-1188. PubMed ID: 29246782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of linear ubiquitinylation, a crucial regulator of NF-κB and cell death, in the immune system.
    Sasaki K; Iwai K
    Immunol Rev; 2015 Jul; 266(1):175-89. PubMed ID: 26085215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.
    Elliott PR; Leske D; Hrdinka M; Bagola K; Fiil BK; McLaughlin SH; Wagstaff J; Volkmar N; Christianson JC; Kessler BM; Freund SM; Komander D; Gyrd-Hansen M
    Mol Cell; 2016 Sep; 63(6):990-1005. PubMed ID: 27591049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.